CoreAge Rx vs Boston Medical Group
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Boston Medical Group head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Boston Medical Group
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Boston Medical Group a bad call — it's best for readers who want a physician consultation and will resolve the conflicting program prices before enrolling. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Boston Medical Group |
|---|---|---|
| Brief Score | 94/100 (A) | 68/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm twelve-week total Public pages give conflicting $699/$999 totals; prescribed formulation, dose and platform fees need a reconciled quote. Full price detailsCurrent semaglutide formulation and complete program quote unknown; conflicting twelve-week totals $699/$999; earlier listing: From $199/mo (starting strength, rising with dose, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm a named-drug quote A general FAQ mention does not establish a current tirzepatide formulation, plan or complete charge. Full price detailsCurrent tirzepatide plan and medication quote unknown; earlier listing: Not disclosed |
| Coverage | US only; restrictions by state, confirmed at intake | Service depends on a clinician licensed where you receive care; confirm current program availability in your state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Boston Medical Group: Cost page lists $699 for twelve weeks; program-steps page lists $999 including a $100 platform fee. Obtain the applicable written quote.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.